Cellular Reprogramming

译名:细胞重编程

SCIEJCR Q2中科院4区

1-3

2026

影响因子区间

平台估算

投稿周期

14%

2025

中国作者发文占比

1969 USD

费用说明

收费

期刊简介:Cellular Reprogramming is the premier journal dedicated to providing new insights on the etiology, development, and potential treatment of various diseases through reprogramming cellular mechanisms. The Journal delivers information on cutting-edge techniques and the latest high-quality research and discoveries that are transforming biomedical research.Cellular Reprogramming coverage includes:Somatic cell nuclear transfer and reprogramming in early embryosEmbryonic stem cellsNuclear transfer stem cells (stem cells derived from nuclear transfer embryos)Generation of induced pluripotent stem (iPS) cells and/or potential for cell-based therapiesEpigeneticsAdult stem cells and pluripotency.

【译文】细胞重编程是专注于通过重编程细胞机制提供关于各种疾病病因、发展和潜在治疗的最新见解的领先期刊。该期刊提供了关于前沿技术和最新高质量研究发现的最新信息,这些发现正在改变生物医学研究。细胞重编程的覆盖范围包括:体细胞核移植和早期胚胎重编程、胚胎干细胞、核移植干细胞(从核移植胚胎中获得的干细胞)、诱导多能干细胞(iPS细胞)的生成和/或基于细胞的治疗潜力、表观遗传学、成体干细胞和多能性。

出版社
Mary Ann Liebert, Inc.
语言
English
学科
医学
ISSN
2152-4971
eISSN
2152-4998
出版频率
双月刊
创刊年份
2010
投稿网址
https://mc.manuscriptcentral.com/cellreprogramming
最近更新
2026-04-02 18:16:40
Cellular Reprogramming

指标当前值近三年趋势
JCR分区Q2
暂无
中科院分区4区
暂无
影响因子区间1-3
暂无